Geneuniversal Inc.

Newark, DE Geneuniversal Inc.

UEI
N5KYVHM3SHD7
CAGE
84BZ4
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
200 Continental Dr #401, Newark, DE 19713, USA
Website
geneuniversal.com
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Geneuniversal Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
DNA services: antibody gene synthesis, subcloning and plasmid preparation (ambis #2228446) Contract · 75N93024P00989 National Institute of Allergy and Infectious Diseases $200,219
152 gene fragments are required to be synthesized and put into a gateway compatible entry vector Contract · 12505B23P0155 Midwest Area $12,312
Custom gene synthesis and plasmid prep Contract · 75N93021P01410 National Institute of Allergy and Infectious Diseases $50,110
Gene synthesis, site-directed mutagenesis, PCR cloning and plasmid preparation Contract · 75N93021P01333 National Institute of Allergy and Infectious Diseases $148,059
Gene synthesis site-directed mutagenesis plasmid prep QTY 200 Contract · 75N93020P01139 National Institute of Allergy and Infectious Diseases $50,541

About Geneuniversal Inc.

Geneuniversal Inc. is a for-profit biotechnology services provider located in Newark, Delaware, specializing in advanced genetic engineering and molecular biology services. Registered in SAM.gov since June 12, 2018, with current registration valid through November 6, 2025, the company focuses on delivering sophisticated DNA-related research and development services to federal government agencies. As a corporate entity, Geneuniversal Inc. has established itself as a critical partner for scientific research institutions, particularly in the fields of vaccine development and genetic research.

The company has consistently provided specialized gene synthesis, molecular cloning, and plasmid preparation services primarily to the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH). Federal contract awards ranging from $10,435 to $200,219 have supported critical research initiatives, including HIV/AIDS vaccine development and agricultural genetic research. Notably, Geneuniversal Inc. has performed services such as antibody gene synthesis, site-directed mutagenesis, PCR cloning, and custom DNA services. Their contracts have been predominantly firm fixed-price purchase orders with no specific set-aside designations. The company has worked directly with federal agencies like NIAID and the USDA Agricultural Research Service, supporting vaccine research, genetic resource development, and biotechnological innovation through precise, custom genetic engineering services.

Quick answers

What is Geneuniversal Inc.'s UEI?

Geneuniversal Inc.'s Unique Entity ID (UEI) in SAM.gov is N5KYVHM3SHD7.

What is Geneuniversal Inc.'s CAGE code?

Geneuniversal Inc.'s CAGE code is 84BZ4.

What is Geneuniversal Inc.'s primary NAICS code?

Geneuniversal Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Geneuniversal Inc. located?

Geneuniversal Inc.'s physical address in SAM.gov is 200 Continental Dr #401, Newark, DE 19713, USA.

Is Geneuniversal Inc. registered in SAM.gov?

Yes. Geneuniversal Inc.'s SAM.gov registration is active through November 17, 2026.

What is Geneuniversal Inc.'s most recent federal award?

Geneuniversal Inc.'s most recent federal contract award is DNA services: antibody gene synthesis, subcloning and plasmid preparation (ambis #2228446) (75N93024P00989), from National Institute of Allergy and Infectious Diseases, on August 14, 2024.

On GovTribe

See Geneuniversal Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors